Florian Scotté (Lee S Schwartzberg, Lee Schwartzberg)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 22

Top Venues

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Cancer medicine

Therapeutic advances in medical oncology

The oncologist

West Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

West Cancer Center

United States

Executive Director

Publications

Ian N Olver, Rebecca Clark-Snow, Christina Halgaard Bruvik Ruhlmann, Maria-Angeles Garcia-Del-Barrio, Florian Scotté, Bernardo Leon Rapoport, Franziska Jahn
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Florian Scotté, Lee Schwartzberg, Hirotoshi Lihara, Matti Aapro, Richard Gralla, Paul J Hesketh, Karin Jordan, Ronald Chow, Jørn Herrstedt
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Ian N Olver, Rebecca Clark-Snow, Christina Halgaard Bruvik Ruhlmann, Maria-Angeles Garcia-Del-Barrio, Florian Scotté, Bernardo Leon Rapoport, Franziska Jahn
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Ian N Olver, Rebecca Clark-Snow, Christina Halgaard Bruvik Ruhlmann, Maria-Angeles Garcia-Del-Barrio, Florian Scotté, Bernardo Leon Rapoport, Franziska Jahn
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Florian Scotté, Lee Schwartzberg, Hirotoshi Lihara, Matti Aapro, Richard Gralla, Paul J Hesketh, Karin Jordan, Ronald Chow, Jørn Herrstedt
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Florian Scotté, Davey Daniel, Daniel Vaena, Dennis Slater, Harry Staszewski, Bruno Fang, Lasika Seneviratne, Elaine Yu, Richard Price, Tania Szado, Craig S Meyer, Anuj Shah, Esprit Ma
Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA. Future oncology (London, England) (2023)
Florian Scotté, Lee Schwartzberg, Hirotoshi Iihara, Matti Aapro, Richard Gralla, Paul J Hesketh, Karin Jordan, Ronald Chow, Jørn Herrstedt
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Ian N Olver, Rebecca Clark-Snow, Christina Halgaard Bruvik Ruhlmann, Maria-Angeles Garcia-Del-Barrio, Florian Scotté, Bernardo Leon Rapoport, Franziska Jahn
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Florian Scotté, Lee Schwartzberg, Hirotoshi Lihara, Matti Aapro, Richard Gralla, Paul J Hesketh, Karin Jordan, Ronald Chow, Jørn Herrstedt
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Bolivar Arboleda-Osorio, Rupert Bartsch, Evandro de Azambuja, Erika Paige Hamilton, Nadia Harbeck, Jennifer R Klemp, Michael Knauer, Sherko Kuemmel, Reshma L Mahtani, Florian Scotté, Cynthia Villarreal Garza, Antonio Wolff
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel. The oncologist 27 (9) (2022)
Ilana Graetz, Xin Hu, Andrea N Curry, Andrew Robles, Gregory A Vidal, Florian Scotté
Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trial. Cancer medicine (2022)
Xin Hu, Cameron M Kaplan, Michelle Y Martin, Mark S Walker, Edward Stepanski, Florian Scotté, Gregory A Vidal, Ilana Graetz
Race differences in patient-reported symptoms during chemotherapy among women with early-stage hormone receptor positive breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
Florian Scotté, Lesli A Kiedrowski
Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation. Therapeutic advances in medical oncology 13 (2021)
Stephen M Schleicher, Basit Chaudhry, Natalie R Dickson, Emeline M Aviki, Edward Arrowsmith, Ravi B Parikh, Andrew T Yue, Nora Connor, Florian Scotté, Aaron J Lyss
Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study. JCO oncology practice 17 (7) (2021)
Patrick Wayne Cobb, Yong Wha Moon, Klára Mezei, István Láng, Gajanan Bhat, Shanta Chawla, Steven J Hasal, Florian Scotté
A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study. Cancer medicine 9 (17) (2020)
Emily Miller, Florian Scotté
Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood. Current treatment options in oncology 21 (11) (2020)
Florian Scotté, Kristi McIntyre, Sharon Wilks, Shannon Puhalla, Joyce O'Shaughnessy, Erhan Berrak, Yaohua He, Linda Vahdat
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer. BMC cancer 19 (1) (2019)
Florian Scotté, Rudolph Navari, Rebecca Clark-Snow, Ekaterine Arkania, Irena Radyukova, Kamal Patel, Daniel Voisin, Giada Rizzi, Rita Wickham, Richard J Gralla, Matti Aapro, Eric Roeland
Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy. The oncologist 25 (3) (2019)
Emily M Miller, Florian Scotté
Biosimilars for breast cancer: a review of HER2-targeted antibodies in the United States. Therapeutic advances in medical oncology 11 (2019)
Florian Scotté, Meinolf Karthaus, Giorgia Rossi, Giada Rizzi, Maria E Borroni, Hope S Rugo, Karin Jordan, Vincent Hansen
Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studies. Cancer medicine 8 (5) (2019)
Florian Scotté, Rudolph M Navari
Safety of Polysorbate 80 in the Oncology Setting. Advances in therapy 35 (6) (2018)
Florian Scotté
Getting it right the first time: recent progress in optimizing antiemetic usage. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 26 (Suppl 1) (2018)

Florian Scotté.css-eqlu8i{font-size:small;padding-left:4px;} (Lee S Schwartzberg, Lee Schwartzberg)

Publication Activity (10 Years)

Top Topics

Top Venues

Florian Scotté (Lee S Schwartzberg, Lee Schwartzberg)